Anton Tscherne: Can you please tell us your name?
Interviewee: Zheng Xiaofei
Anton Tscherne: What is the name of the company that you work for?
Interviewee: Biomobie (Shanghai) Regenerative Medicine Technology Co., Ltd.
Anton Tscherne: What position do you hold in the company?
Interviewee: I am a doctor of the companies medical center
Anton Tscherne: How many employees are there in the company?
Interviewee: About 69
Anton Tscherne: Which city is your company located in?
Interviewee: Jiaxing
Anton Tscherne: What year was your company established? Is there anything to say about the course of development?
Interviewee: the company was founded in April 2014. The biologic regeneration factor library and bioelectronic medicine library, owned by Biomobie, are composed of dozens of electronic formulations among which Biomobie R7 BBT-I, which contributes to the regeneration of endothelial progenitor cells, is only one of them. The WHO predicts that the within the next century healthcare systems will be dominated by preventive medicine systems.
The two major factor Library of Biomobie R7 will become a new life prevention and rehabilitation system modeled after western and Chinese medicine. This system represents advanced preventive medicine. It is known as the future of medicine by helping to restore the growth of the organs and cells in the body and regulate the activity and metabolic level of the cells in the body, thus promoting the recovery of various chronic diseases.
The successful development of R7 is a major disruptive breakthrough in the field of human regenerative medicine and will become an important milestone in the history of human life medicine.
Anton Tscherne: Why are you engage in your current career? Are there any stories about it?
Interviewee: Because I love the health industry. Professional testing equipment and instruments can help people in need. The country is also building healthy China, and the health industry is a sunrise industry in the future.
Anton Tscherne: could you tell us about your company's development and direction?
Interviewee: Biomobie is a regenerative medical institution with a number of bioelectricity "noninvasive vascular normalization" global patents. Its IT R & D center and product design center are located in Silicon Valley in the United States. The medical clinical research and development base is located in the United States and China, and the product application and production base is located in Shanghai, China. The Biomobie non-invasive vascular regeneration technology developed by Biomobie has broken through the uncontrolled chronic disease treatment bottlenecks after the vascular microcirculation is damaged. The Harvard University and the American Mayo Clinic in the United States, have taken the lead in the conclusion of the effectiveness of Biomobie in the treatment of insomnia and the recovery of heart and lung function. After three years, Biomobie completed 60 thousand chronic cases. The efficacy of the disease was verified; in 2014, SFDA, FDA and CE were granted market access permits. The technology is expected to become the third effective new therapy to control chronic diseases after medicine and vaccine, quietly repeating the history of smallpox conquering smallpox.
Patent Certificate
Anton Tscherne: what is the main product or service of your company? What competitive advantage does it have in the market?
Interviewee: the company's product is the core of life. It mainly reduces blood pressure, improves microcirculation, improves stroke, increases blood supply to the heart, strengthens the body's immunity and improves arthritis, and improves the function of the digestive system by improving sexual function.
[Mechanism of self-repair of human disease]
Life science believes that the body itself is an organic whole with its own regulation, repair and balance functions. Our brain is in accordance with the genetic process, through the nervous system, to implement viscera and limb system management. In this regard, scientists have carried out a long-term study and finally found that the target of the viscera body can be restored by activating the balance control system of the body itself. For example, the "R7" Bioboosti technology, by activating the endothelial regeneration mechanism of blood vessels, can repair damaged blood vessels and promote the body to achieve a new equilibrium.
[Modern biological theory of human self repair]
In 1961, Robert Becker published his findings in the world's most famous surgical journal, "Journal of Bone and Joint Surgery": the start engine of animal and human post-traumatic regeneration is a direct direct current signal from the trauma of the nerve flow. This theory has been widely recognized worldwide. Dr. Becker confirms that after the injury in animals and human bodies, the nerve in the injured place produces an instantaneous current regeneration signal. When the brain receives the current signal, it will quickly stimulate a variety of proembryonic cells to repair and regenerate the nerve, blood vessel, muscle and bone in the wound. The discovery of the theory of "traumatic current" is another explanation of modern western medicine to ancient Chinese medicine.
[Regenerative cure of damaged organs]
After damage to plants and animals, the damaged parts can be repaired through their own regeneration and repair mechanisms. Human beings have the same ability to regenerate and repair. Scientists have found that the rehabilitation of a variety of chronic diseases will be the simplest, safe and most effective means of health recovery if people can restore the mechanism of regenerative repair of a damaged organ in the body.
[The phenomenon of natural organ regeneration]
Much data and literature show that in nature, regeneration is not only applicable to plants, but any living animal has varying degrees of regeneration. Since the French scientist Rene 'Antoine Ferchautt de Reaumar described biological regeneration in the theory of regenerative medicine in 1712, the Italian biologist Clazaaro Spallanzani found the limb regeneration of Salamander (salamander), and he also found that young Salamander were stronger than the older Salamander. The ability of regeneration and the regeneration potential of low-level animals are higher than that of advanced animals. This conclusion indicates that human beings are at the end of the list of organ regeneration. In 1970, a few days after a child's finger was cut off in Sheffield Children 's Hospital, UK, surgeon Cynthia Illingworth discovered that the child's finger began a miracle of regeneration, and the child's fingers were completely restored as time went on. Since then, she has documented hundreds of cases of finger regeneration in children under 11 years of age.
[Natural heart regeneration]
1914 - a German biological report pointed out that a small area of myocardial damage caused by diphtheria was found in human babies themselves.
1950 - the Soviet biologist N. P. Sinitsyn successfully repaired a 16 square millimeter heart hole in a dog.
1954 - biologist Pauel Rumyantseu released the case of mammalian adult rats and new kittens to repair minor heart injuries.
1973 - Rotert O. Becker, a famous American biologist, discovered that the heart of Lazarus (lizard) can be rapidly regenerated within a few hours after being cut. Dr Becher also found that Blastema cells (proembryo cells) reversed and produced cardiomyocytes.
1978 -1979, the Bruce Carlson and Phil Person of University of Michigan in the United States also confirmed this cell reversal of regenerative cardiomyocytes from the electron microscope.
[Theory of regeneration of animal organs]
In 1961, Robert Becker published his discovery in the world's most famous surgical journal, "Journal of Bone and Joint Surgery" - a DC electrical signal along the nerve flow. Becker confirms that after the injured animal or human body, the nerve produces an instantaneous current signal in the injured area. When the brain receives this signal, it will quickly command a variety of proembryonic cells to repair and regenerate the nerve, blood vessel, muscle and bone in the wound.
[Application results of regenerative theory]
The US space agency NASA used PEMF technology to solve the problem of astronaut osteoporosis and muscle atrophy. When American astronauts entered the earth to return to earth, they found osteoporosis and muscle atrophy, due to the fact that astronauts were divorced from the gravity and dynamic magnetic field of human existence. The US space agency has conducted an in-depth study of PEMF technology, and confirmed that PEMF plays a unique role in promoting the growth of multiple cells. NASA used this research achievement to successfully carry out skeletal and muscular rehabilitation for astronauts.
Regenerative science and technology]
According to the above theory, the biomobi scientists have studied it in depth and found that the damage to the cardiovascular system is a long process of accumulation, so it does not produce a wound regenerative repair current signal. In order to induce the brain to initiate a damaged cardiovascular regenerative repair program, a cardiovascular regeneration signal (traumatic current signal) must be simulated in the human body. Life nuclear technology continues to use wound current code signal as a necessary condition for biological regeneration. In the human body, the simulation generates a set of regenerated current coded signals of cardiovascular damage, thereby helping the brain start regenerative repair procedures for damaged cardiovascular system.
"R7" Bioboosti technology has undergone thousands of experiments, and no toxic and side effects and cell mutation have been found.
Anton Tscherne: is there an official website for your company? Please tell us your website url or more ways we can find info about your company on the Internet.
Interviewee: the website is www.biomobie.com
Anton Tscherne: if anyone wants to know more about you and your company, how can they contact you?
Interviewee: please send email to: 2659652983@qq.com
